Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(25 sites)
United States
Limb Preservation Platform, Inc, Fresno, California Angel City Research,Inc, Los Angeles, California Center for Clinical Research INC, San Francisco, California ILD Research Center, Vista, California University of Miami, Miami, Florida Massachusetts General Hospital, Boston, Massachusetts Boston Medical Center, Boston, Massachusetts Rutgers New Jersey Medical Center, Newark, New Jersey Northwell Health Comprehensive Wound Healing Center, Lake Success, New York NYU Langone Health Long Island - Research & Academic Center, Mineola, New York Mount Sinai West, New York, New York Cutting Edge Research LLC.,, Circleville, Ohio Clinical Trial Network Houston, Houston, Texas Woundcentrics, LLC, San Antonio, Texas Austria
Medical University of Graz, Graz Medical University Wien, Vienna Germany
Ruhr-University Bochum, Bochum Städtisches Klinikum Dresden, Dresden Wundzentrum Dermatologie Erlangen, Erlangen DermaKiel - Allergie und Haut Centrum, Kiel Israel
Asaf Harofeh (Shamir) Medical Center, Be’er Ya‘aqov Kaplan Medical Center, Rehovot Poland
Allmedica Badania Kliniczne, Nowy Targ Centrum medyczne Solumed, Poznan